Search
Chigene Biotechnology Secures Tens of Millions of Yuan in Pre-A+ Funding Round
2025-11-18 /
Read about 0 minute
Author：小编
Recently, Tianjin Chigene Biotechnology Co., Ltd. has proudly announced the successful closure of its Pre-A+ funding round, raising tens of millions of yuan. This significant investment was a collaborative effort between National Science and Technology Venture Capital and the Tianjin Port Free Trade Zone Industrial Development Fund. Dianshi Capital played a pivotal role as the exclusive financial advisor for this round. The funds raised will be strategically allocated to expedite the development and commercialization of equipment products. Additionally, they will facilitate a comprehensive enhancement of the company's gene synthesis service capabilities, aligning with international standards and industry best practices.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
